Position in RZLT
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$75,106
+$40,591 QoQ
Shares Held
24,625
+68.4% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MML INVESTORS SERVICES, LLC holds $68,664,661 across 56 Biotechnology names. RZLT ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,419 | $14,922,920 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,009 | $13,141,833 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,482 | $5,122,529 | |
| 4 | ARGX |
Argenx SE
|
6,011 | $4,389,532 | |
| 5 | INSM |
INSMED Inc
|
24,773 | $4,050,880 | |
| 6 | RPRX |
Royalty Pharma plc
|
42,269 | $2,027,643 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
58,950 | $1,964,214 | |
| 8 | EXEL |
Exelixis, Inc.
|
40,961 | $1,756,817 |
All Filings in RZLT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,106 | 24,625 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $34,515 | 14,625 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $130,763 | 13,911 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $50,489 | 17,410 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $65,709 | 13,410 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $56,551 | 11,660 | Shares | Defined | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||